首页 > 最新文献

Wounds : a compendium of clinical research and practice最新文献

英文 中文
Use of homologous platelet gel to manage refractory diabetic lower extremity ulcers: additional experience at a tertiary hospital. 使用同种血小板凝胶治疗难治性糖尿病下肢溃疡:一家三甲医院的额外经验。
IF 1.7 4区 医学 Q3 DERMATOLOGY Pub Date : 2023-11-01 DOI: 10.25270/wnds/23011
Sara Ferreira, Marco Sampaio, Margarida Oliveira, Francisco Dias, Eduarda Valente, Maria Luís Queirós, R. Guimarães, Joel Pereira, Helena Neto, Rui Carvalho, Marika Bini Antunes
BACKGROUND DLEUs are a major cause of morbidity. Appropriate treatment is essential, and newer methods to achieve ulcer healing have been described, including application of PG. OBJECTIVE This study evaluated the effectiveness and safety of homologous PG in patients with chronic noninfected DLEU refractory to standard treatment as well as possible correlations between patient comorbidities and response to treatment. MATERIALS AND METHODS Data from patients with chronic refractory DLEU managed with homologous PG between January 2014 and October 2022 were evaluated (comorbidities, wound characteristics, number and time of treatment, outcome). Outcome was classified as complete response (complete ulcer healing with reepithelialization), partial response (≥50% reduction in area and/or improvement of pain), or absence of response. The chi-square test was used to compare groups, with alpha level set at less than .05. RESULTS A total of 81 patients (63 male, 18 female; median age, 65 years; median HbA1c, 7.6%; median ulcer area, 2.9 cm2) were proposed for PG application. A total of 62 patients had 3 or more comorbidities. Outcome was evaluated in 69 patients, with response observed in 49% (complete, 32%; partial, 17%). Worse outcomes occurred in patients with polyneuropathy (chi-square statistic: 4.183; P = .041). CONCLUSION Homologous PG is a safe and possibly effective therapeutic alternative for DLEU that is unresponsive to standard therapies.
背景 白血病溃疡是发病的主要原因。适当的治疗是必不可少的,目前已经出现了实现溃疡愈合的新方法,包括应用 PG。 目的 本研究评估了标准治疗难治的慢性非感染性 DLEU 患者使用同种异体 PG 的有效性和安全性,以及患者合并症和治疗反应之间可能存在的相关性。 材料与方法 评估了2014年1月至2022年10月期间接受同种异体PG治疗的慢性难治性白LEU患者的数据(合并症、伤口特征、治疗次数和时间、结果)。结果分为完全应答(溃疡完全愈合并再上皮化)、部分应答(面积缩小≥50%和/或疼痛改善)或无应答。组间比较采用卡方检验,α水平设为小于 0.05。 结果 共有 81 名患者(63 名男性,18 名女性;年龄中位数,65 岁;HbA1c 中位数,7.6%;溃疡面积中位数,2.9 平方厘米)被建议应用 PG。共有 62 名患者患有 3 种或更多合并症。对 69 名患者的疗效进行了评估,结果显示 49% 的患者有反应(完全反应 32%;部分反应 17%)。多发性神经病患者的疗效较差(卡方统计:4.183;P = .041)。 结论 对于标准疗法无效的 DLEU,同源 PG 是一种安全且可能有效的替代疗法。
{"title":"Use of homologous platelet gel to manage refractory diabetic lower extremity ulcers: additional experience at a tertiary hospital.","authors":"Sara Ferreira, Marco Sampaio, Margarida Oliveira, Francisco Dias, Eduarda Valente, Maria Luís Queirós, R. Guimarães, Joel Pereira, Helena Neto, Rui Carvalho, Marika Bini Antunes","doi":"10.25270/wnds/23011","DOIUrl":"https://doi.org/10.25270/wnds/23011","url":null,"abstract":"BACKGROUND DLEUs are a major cause of morbidity. Appropriate treatment is essential, and newer methods to achieve ulcer healing have been described, including application of PG. OBJECTIVE This study evaluated the effectiveness and safety of homologous PG in patients with chronic noninfected DLEU refractory to standard treatment as well as possible correlations between patient comorbidities and response to treatment. MATERIALS AND METHODS Data from patients with chronic refractory DLEU managed with homologous PG between January 2014 and October 2022 were evaluated (comorbidities, wound characteristics, number and time of treatment, outcome). Outcome was classified as complete response (complete ulcer healing with reepithelialization), partial response (≥50% reduction in area and/or improvement of pain), or absence of response. The chi-square test was used to compare groups, with alpha level set at less than .05. RESULTS A total of 81 patients (63 male, 18 female; median age, 65 years; median HbA1c, 7.6%; median ulcer area, 2.9 cm2) were proposed for PG application. A total of 62 patients had 3 or more comorbidities. Outcome was evaluated in 69 patients, with response observed in 49% (complete, 32%; partial, 17%). Worse outcomes occurred in patients with polyneuropathy (chi-square statistic: 4.183; P = .041). CONCLUSION Homologous PG is a safe and possibly effective therapeutic alternative for DLEU that is unresponsive to standard therapies.","PeriodicalId":23752,"journal":{"name":"Wounds : a compendium of clinical research and practice","volume":"37 1","pages":"E408-E413"},"PeriodicalIF":1.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139301575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of homologous platelet gel to manage refractory diabetic lower extremity ulcers: additional experience at a tertiary hospital. 使用同源血小板凝胶治疗难治性糖尿病下肢溃疡:在三级医院的额外经验。
IF 1.7 4区 医学 Q3 DERMATOLOGY Pub Date : 2023-11-01
Sara Ferreira, Marco Sampaio, Margarida Oliveira, Francisco Dias, Eduarda Valente, Maria Luís Queirós, Rosa Guimarães, Joel Pereira, Helena Neto, Rui Carvalho, Marika Bini Antunes

Background: DLEUs are a major cause of morbidity. Appropriate treatment is essential, and newer methods to achieve ulcer healing have been described, including application of PG.

Objective: This study evaluated the effectiveness and safety of homologous PG in patients with chronic noninfected DLEU refractory to standard treatment as well as possible correlations between patient comorbidities and response to treatment.

Materials and methods: Data from patients with chronic refractory DLEU managed with homologous PG between January 2014 and October 2022 were evaluated (comorbidities, wound characteristics, number and time of treatment, outcome). Outcome was classified as complete response (complete ulcer healing with reepithelialization), partial response (≥50% reduction in area and/or improvement of pain), or absence of response. The chi-square test was used to compare groups, with alpha level set at less than .05.

Results: A total of 81 patients (63 male, 18 female; median age, 65 years; median HbA1c, 7.6%; median ulcer area, 2.9 cm2) were proposed for PG application. A total of 62 patients had 3 or more comorbidities. Outcome was evaluated in 69 patients, with response observed in 49% (complete, 32%; partial, 17%). Worse outcomes occurred in patients with polyneuropathy (chi-square statistic: 4.183; P = .041).

Conclusion: Homologous PG is a safe and possibly effective therapeutic alternative for DLEU that is unresponsive to standard therapies.

背景:dleu是发病的主要原因。适当的治疗是必不可少的,新的方法来实现溃疡愈合已经被描述,包括应用PG。目的:本研究评估同源PG在慢性非感染性DLEU患者的有效性和安全性,以及患者合并症与治疗反应之间可能的相关性。材料和方法:对2014年1月至2022年10月间接受同源PG治疗的慢性难治性DLEU患者的数据进行评估(合并症、伤口特征、治疗次数和时间、结果)。结果分为完全缓解(溃疡完全愈合伴再上皮化)、部分缓解(面积缩小≥50%和/或疼痛改善)或无缓解。组间比较采用卡方检验,α水平设为小于0.05。结果:共81例患者,其中男63例,女18例;中位年龄65岁;中位HbA1c为7.6%;溃疡中位面积2.9 cm2)建议应用PG。共有62例患者有3种或3种以上合并症。对69例患者的结果进行了评估,49%的患者观察到缓解(完全,32%;部分,17%)。多发性神经病患者预后较差(卡方统计量:4.183;P = .041)。结论:同源PG是一种安全有效的治疗方法,可用于治疗对标准治疗无反应的DLEU。
{"title":"Use of homologous platelet gel to manage refractory diabetic lower extremity ulcers: additional experience at a tertiary hospital.","authors":"Sara Ferreira, Marco Sampaio, Margarida Oliveira, Francisco Dias, Eduarda Valente, Maria Luís Queirós, Rosa Guimarães, Joel Pereira, Helena Neto, Rui Carvalho, Marika Bini Antunes","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>DLEUs are a major cause of morbidity. Appropriate treatment is essential, and newer methods to achieve ulcer healing have been described, including application of PG.</p><p><strong>Objective: </strong>This study evaluated the effectiveness and safety of homologous PG in patients with chronic noninfected DLEU refractory to standard treatment as well as possible correlations between patient comorbidities and response to treatment.</p><p><strong>Materials and methods: </strong>Data from patients with chronic refractory DLEU managed with homologous PG between January 2014 and October 2022 were evaluated (comorbidities, wound characteristics, number and time of treatment, outcome). Outcome was classified as complete response (complete ulcer healing with reepithelialization), partial response (≥50% reduction in area and/or improvement of pain), or absence of response. The chi-square test was used to compare groups, with alpha level set at less than .05.</p><p><strong>Results: </strong>A total of 81 patients (63 male, 18 female; median age, 65 years; median HbA1c, 7.6%; median ulcer area, 2.9 cm2) were proposed for PG application. A total of 62 patients had 3 or more comorbidities. Outcome was evaluated in 69 patients, with response observed in 49% (complete, 32%; partial, 17%). Worse outcomes occurred in patients with polyneuropathy (chi-square statistic: 4.183; P = .041).</p><p><strong>Conclusion: </strong>Homologous PG is a safe and possibly effective therapeutic alternative for DLEU that is unresponsive to standard therapies.</p>","PeriodicalId":23752,"journal":{"name":"Wounds : a compendium of clinical research and practice","volume":"35 11","pages":"E408-E413"},"PeriodicalIF":1.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138483148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus recommendations for optimizing the use of intact fish skin graft in the management of acute and chronic lower extremity wounds. 一致建议优化完整鱼皮移植在急性和慢性下肢伤口治疗中的应用。
IF 1.7 4区 医学 Q3 DERMATOLOGY Pub Date : 2023-11-01
Anthony Tickner, Frank Aviles, Robert Kirsner, Eric Lullove, Leah Main, Mark Suski, Naz Wahab, John C Lantis Ii

Background: Since 2017, the clinical use of IFSG has increased substantially in the United States, with some use in Europe and Asia as well. However, scant consensus data have been published on such use.

Objective: The authors sought to develop consensus recommendations for the clinical use of IFSG in the management of acute and chronic LEWs.

Methods: A panel of 8 expert clinicians in the United States used a 2-cycle NFG process to develop consensus statements based on their own clinical practice and the literature. At their initial meeting in October 2021, panel members discussed the management of DFUs, VLUs, atypical LEWs, and traumatic LEWs in their practices. Consensus statements were drafted, voted on, and rated by relative importance. At the second meeting in October 2022, the panel discussed the initial survey results; a second survey was conducted, and panel members revised the recommendations and indicated the relative importance of each in the final report. A systematic literature review of English-language articles published from January 2016 through November 2022 was conducted as well, using the search terms: "fish skin," "piscine graft," "fish tissue," "intact fish skin graft," "Cod skin," "Omega 3 fatty acid graft."

Results: Forty-three statements were generated and grouped into 5 sections comprising general recommendations for LEWs and recommendations specific to DFUs, VLUs, atypical LEWs, and traumatic LEWs. The primary general recommendation is the need to determine wound etiology based on clinical evaluation and reviewing related test results. For DFUs and VLUs, the main recommendations are to adhere to first-line therapy (ie, standard of care, follow conventional guidelines [multilayer compression therapy], offloading, and assessment of wound perfusion) before introducing IFSG.

Conclusions: Publications on and clinical experience in the use of IFSGs have increased substantially in the past several years. The 43 consensus recommendations are meant to guide physicians in the optimal use of IFSG in the management of acute and chronic LEWs.

背景:自2017年以来,IFSG在美国的临床使用大幅增加,在欧洲和亚洲也有一些使用。然而,关于这种使用的共识数据很少发表。目的:作者试图就IFSG在急性和慢性LEWs治疗中的临床应用提出共识建议。方法:一个由8位美国临床专家组成的小组,根据他们自己的临床实践和文献,使用了一个2周期的NFG过程来制定共识声明。在2021年10月的首次会议上,小组成员讨论了在实践中对dfu、vlu、非典型LEWs和创伤性LEWs的管理。协商一致的声明被起草、投票并按相对重要性排序。在2022年10月的第二次会议上,小组讨论了初步调查结果;进行了第二次调查,小组成员修订了建议,并在最后报告中指出了每项建议的相对重要性。对2016年1月至2022年11月期间发表的英语文章进行了系统的文献综述,使用搜索词:“鱼皮”、“鱼移植”、“鱼组织”、“完整的鱼皮移植”、“鳕鱼皮”、“Omega - 3脂肪酸移植”。结果:生成了43份陈述,并分为5部分,包括对LEWs的一般建议和对dfu、vlu、非典型LEWs和创伤性LEWs的具体建议。主要的一般建议是需要根据临床评估和回顾相关的测试结果来确定伤口的病因。对于dfu和vlu,主要建议是在引入IFSG之前坚持一线治疗(即标准护理,遵循常规指南[多层压迫治疗],卸载和评估伤口灌注)。结论:在过去几年中,关于IFSGs使用的出版物和临床经验显著增加。43项共识建议旨在指导医生在急性和慢性LEWs管理中最佳使用IFSG。
{"title":"Consensus recommendations for optimizing the use of intact fish skin graft in the management of acute and chronic lower extremity wounds.","authors":"Anthony Tickner, Frank Aviles, Robert Kirsner, Eric Lullove, Leah Main, Mark Suski, Naz Wahab, John C Lantis Ii","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Since 2017, the clinical use of IFSG has increased substantially in the United States, with some use in Europe and Asia as well. However, scant consensus data have been published on such use.</p><p><strong>Objective: </strong>The authors sought to develop consensus recommendations for the clinical use of IFSG in the management of acute and chronic LEWs.</p><p><strong>Methods: </strong>A panel of 8 expert clinicians in the United States used a 2-cycle NFG process to develop consensus statements based on their own clinical practice and the literature. At their initial meeting in October 2021, panel members discussed the management of DFUs, VLUs, atypical LEWs, and traumatic LEWs in their practices. Consensus statements were drafted, voted on, and rated by relative importance. At the second meeting in October 2022, the panel discussed the initial survey results; a second survey was conducted, and panel members revised the recommendations and indicated the relative importance of each in the final report. A systematic literature review of English-language articles published from January 2016 through November 2022 was conducted as well, using the search terms: \"fish skin,\" \"piscine graft,\" \"fish tissue,\" \"intact fish skin graft,\" \"Cod skin,\" \"Omega 3 fatty acid graft.\"</p><p><strong>Results: </strong>Forty-three statements were generated and grouped into 5 sections comprising general recommendations for LEWs and recommendations specific to DFUs, VLUs, atypical LEWs, and traumatic LEWs. The primary general recommendation is the need to determine wound etiology based on clinical evaluation and reviewing related test results. For DFUs and VLUs, the main recommendations are to adhere to first-line therapy (ie, standard of care, follow conventional guidelines [multilayer compression therapy], offloading, and assessment of wound perfusion) before introducing IFSG.</p><p><strong>Conclusions: </strong>Publications on and clinical experience in the use of IFSGs have increased substantially in the past several years. The 43 consensus recommendations are meant to guide physicians in the optimal use of IFSG in the management of acute and chronic LEWs.</p>","PeriodicalId":23752,"journal":{"name":"Wounds : a compendium of clinical research and practice","volume":"35 11","pages":"E376-E390"},"PeriodicalIF":1.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138483146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes of selective plantar fascia release for hallux interphalangeal joint ulcers. 选择性足底筋膜松解术治疗拇指间关节溃疡的临床效果。
IF 1.7 4区 医学 Q3 DERMATOLOGY Pub Date : 2023-11-01 DOI: 10.25270/wnds/23093
Fahad Hussain, Shivani Kotwal, Nishka Utpat, Sandeepa Utpat, P. Phadtare, Robin Lenz
BACKGROUND Plantar hallux IPJ ulcers are common and challenging to manage, with many available treatments. One newer technique called SPFR has been used in the management of plantar forefoot ulcers. OBJECTIVE This case series reports the clinical results of SPFR for treatment of strictly plantar hallux IPJ ulcers. MATERIALS AND METHODS A retrospective chart review was conducted on patients that underwent SPFR procedure by a single foot and ankle surgeon from 2018 to 2023. The primary study outcome was to identify the rate and time of healing associated with SPFR for hallux IPJ ulcers. Only the initial surgery was evaluated for time of healing for the ulcer, healing rate, and complications. Subsequent surgeries were reviewed as well. Patient charts were further reviewed to determine the presence or absence of a postoperative complication. RESULTS A total of 17 feet from 17 patients were studied. The hallux IPJ ulcers healed in an average of 3.0 months. The average follow-up time was 26.9 months. Fifteen patients (88.2%) healed after the SPFR procedure. Five patients (29.4%) developed transfer lesions, and 7 patients (41.2%) developed postoperative complications. CONCLUSIONS The authors believe that SPFR can be utilized in the treatment of hallux IPJ ulcers if both surgeons and patients are aware of the potential complications and limitations of this procedure. Further research is warranted to evaluate the efficacy and reproducibility of these results.
背景足底溃疡是一种常见的足底溃疡,治疗难度很大,目前有多种治疗方法。一种名为 SPFR 的新技术已被用于治疗足底溃疡。 目的 本系列病例报告了 SPFR 治疗严格意义上的足底 IPJ 溃疡的临床效果。 材料与方法 对 2018 年至 2023 年期间由一名足踝外科医生接受 SPFR 手术的患者进行了回顾性病历审查。主要研究结果是确定SPFR治疗Hallux IPJ溃疡的相关愈合率和时间。仅对首次手术的溃疡愈合时间、愈合率和并发症进行评估。随后的手术也进行了审查。还进一步查看了患者病历,以确定是否存在术后并发症。 结果 共研究了 17 名患者的 17 只脚。脚掌 IPJ 溃疡平均在 3.0 个月内愈合。平均随访时间为 26.9 个月。15 名患者(88.2%)在 SPFR 术后痊愈。5名患者(29.4%)出现转移灶,7名患者(41.2%)出现术后并发症。 结论 作者认为,如果外科医生和患者都了解该手术的潜在并发症和局限性,SPFR 可用于治疗躅骨 IPJ 溃疡。有必要开展进一步研究,以评估这些结果的有效性和可重复性。
{"title":"Clinical outcomes of selective plantar fascia release for hallux interphalangeal joint ulcers.","authors":"Fahad Hussain, Shivani Kotwal, Nishka Utpat, Sandeepa Utpat, P. Phadtare, Robin Lenz","doi":"10.25270/wnds/23093","DOIUrl":"https://doi.org/10.25270/wnds/23093","url":null,"abstract":"BACKGROUND Plantar hallux IPJ ulcers are common and challenging to manage, with many available treatments. One newer technique called SPFR has been used in the management of plantar forefoot ulcers. OBJECTIVE This case series reports the clinical results of SPFR for treatment of strictly plantar hallux IPJ ulcers. MATERIALS AND METHODS A retrospective chart review was conducted on patients that underwent SPFR procedure by a single foot and ankle surgeon from 2018 to 2023. The primary study outcome was to identify the rate and time of healing associated with SPFR for hallux IPJ ulcers. Only the initial surgery was evaluated for time of healing for the ulcer, healing rate, and complications. Subsequent surgeries were reviewed as well. Patient charts were further reviewed to determine the presence or absence of a postoperative complication. RESULTS A total of 17 feet from 17 patients were studied. The hallux IPJ ulcers healed in an average of 3.0 months. The average follow-up time was 26.9 months. Fifteen patients (88.2%) healed after the SPFR procedure. Five patients (29.4%) developed transfer lesions, and 7 patients (41.2%) developed postoperative complications. CONCLUSIONS The authors believe that SPFR can be utilized in the treatment of hallux IPJ ulcers if both surgeons and patients are aware of the potential complications and limitations of this procedure. Further research is warranted to evaluate the efficacy and reproducibility of these results.","PeriodicalId":23752,"journal":{"name":"Wounds : a compendium of clinical research and practice","volume":"23 1","pages":"E394-E398"},"PeriodicalIF":1.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139302689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wound excision and closure by secondary intention and growth factor application in the management of rosacea complicated by giant rhinophyma. 在治疗并发巨大鼻赘瘤的酒渣鼻时,通过二次意向和应用生长因子进行伤口切除和闭合。
IF 1.7 4区 医学 Q3 DERMATOLOGY Pub Date : 2023-11-01 DOI: 10.25270/wnds/23064
Fan Zhang, Zhehao Shi, Lei Cai, Bin Chen, Wei Qiu, Li Zhang, Xiaohua Lin
BACKGROUND Rosacea is a significant problem, affecting 5.5% of the world population. Currently used treatment techniques such as transfer flaps and implants are insufficient to meet the needs of many patients, which suggests that alternative approaches are needed. CASE REPORT This report describes a case of rosacea complicated by giant rhinophyma treated with excision and closure by secondary intention and growth factor application. The patient was admitted to the Department of Dermatology at The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China, in July 2021, and underwent excision of the external nasal redundancy under general anesthesia. The postoperative wound was left open. The patient's wounds healed completely 2 months after surgery, and there was no recurrence at 6-month follow-up. The wounds recovered well, with only slight scarring. CONCLUSION The positive outcomes for this patient suggest that wound excision and closure by secondary intention and growth factor application may be beneficial for patients with rosacea complicated by giant rhinophyma.
背景 红斑痤疮是一个严重的问题,影响着全球 5.5%的人口。目前使用的转移皮瓣和植入物等治疗技术不足以满足许多患者的需求,这表明需要采用其他方法。 病例报告 本报告描述了一例红斑痤疮并发巨大鼻赘瘤的病例,患者接受了二次意向切除和闭合治疗,并应用了生长因子。患者于 2021 年 7 月入住温州医科大学附属第一医院皮肤科,在全麻下接受了外鼻赘瘤切除术。术后伤口开放。患者术后 2 个月伤口完全愈合,随访 6 个月无复发。伤口恢复良好,仅留下轻微疤痕。 结论 该患者的积极治疗结果表明,通过二次意向和应用生长因子进行伤口切除和闭合可能对并发巨大鼻赘瘤的酒渣鼻患者有益。
{"title":"Wound excision and closure by secondary intention and growth factor application in the management of rosacea complicated by giant rhinophyma.","authors":"Fan Zhang, Zhehao Shi, Lei Cai, Bin Chen, Wei Qiu, Li Zhang, Xiaohua Lin","doi":"10.25270/wnds/23064","DOIUrl":"https://doi.org/10.25270/wnds/23064","url":null,"abstract":"BACKGROUND Rosacea is a significant problem, affecting 5.5% of the world population. Currently used treatment techniques such as transfer flaps and implants are insufficient to meet the needs of many patients, which suggests that alternative approaches are needed. CASE REPORT This report describes a case of rosacea complicated by giant rhinophyma treated with excision and closure by secondary intention and growth factor application. The patient was admitted to the Department of Dermatology at The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China, in July 2021, and underwent excision of the external nasal redundancy under general anesthesia. The postoperative wound was left open. The patient's wounds healed completely 2 months after surgery, and there was no recurrence at 6-month follow-up. The wounds recovered well, with only slight scarring. CONCLUSION The positive outcomes for this patient suggest that wound excision and closure by secondary intention and growth factor application may be beneficial for patients with rosacea complicated by giant rhinophyma.","PeriodicalId":23752,"journal":{"name":"Wounds : a compendium of clinical research and practice","volume":"5 1","pages":"E391-E393"},"PeriodicalIF":1.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139300057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Consensus recommendations for optimizing the use of intact fish skin graft in the management of acute and chronic lower extremity wounds. 在治疗急性和慢性下肢伤口时优化使用完整鱼皮移植的共识建议。
IF 1.7 4区 医学 Q3 DERMATOLOGY Pub Date : 2023-11-01 DOI: 10.25270/wnds/23130
Anthony Tickner, Frank Aviles, Robert Kirsner, E. Lullove, Leah Main, Mark Suski, Naz Wahab, J. C. Lantis Ii
BACKGROUND Since 2017, the clinical use of IFSG has increased substantially in the United States, with some use in Europe and Asia as well. However, scant consensus data have been published on such use. OBJECTIVE The authors sought to develop consensus recommendations for the clinical use of IFSG in the management of acute and chronic LEWs. METHODS A panel of 8 expert clinicians in the United States used a 2-cycle NFG process to develop consensus statements based on their own clinical practice and the literature. At their initial meeting in October 2021, panel members discussed the management of DFUs, VLUs, atypical LEWs, and traumatic LEWs in their practices. Consensus statements were drafted, voted on, and rated by relative importance. At the second meeting in October 2022, the panel discussed the initial survey results; a second survey was conducted, and panel members revised the recommendations and indicated the relative importance of each in the final report. A systematic literature review of English-language articles published from January 2016 through November 2022 was conducted as well, using the search terms: "fish skin," "piscine graft," "fish tissue," "intact fish skin graft," "Cod skin," "Omega 3 fatty acid graft." RESULTS Forty-three statements were generated and grouped into 5 sections comprising general recommendations for LEWs and recommendations specific to DFUs, VLUs, atypical LEWs, and traumatic LEWs. The primary general recommendation is the need to determine wound etiology based on clinical evaluation and reviewing related test results. For DFUs and VLUs, the main recommendations are to adhere to first-line therapy (ie, standard of care, follow conventional guidelines [multilayer compression therapy], offloading, and assessment of wound perfusion) before introducing IFSG. CONCLUSIONS Publications on and clinical experience in the use of IFSGs have increased substantially in the past several years. The 43 consensus recommendations are meant to guide physicians in the optimal use of IFSG in the management of acute and chronic LEWs.
背景自 2017 年以来,IFSG 的临床使用在美国大幅增加,在欧洲和亚洲也有一些使用。然而,有关此类使用的共识数据却寥寥无几。 目的 作者试图就 IFSG 在急性和慢性 LEWs 治疗中的临床应用制定共识建议。 方法 由美国 8 位临床专家组成的小组采用两周期 NFG 流程,根据他们自己的临床实践和文献资料制定共识声明。在 2021 年 10 月举行的首次会议上,专家组成员讨论了其临床实践中对 DFU、VLU、非典型 LEW 和创伤性 LEW 的管理。会议起草了共识声明,对其进行了投票,并按相对重要性进行了评级。在 2022 年 10 月举行的第二次会议上,专家小组讨论了初步调查结果;进行了第二次调查,专家小组成员对建议进行了修订,并在最终报告中指出了每项建议的相对重要性。此外,还对 2016 年 1 月至 2022 年 11 月期间发表的英文文章进行了系统的文献综述,检索词为"鱼皮"、"鱼移植"、"鱼组织"、"完整鱼皮移植"、"鳕鱼皮"、"欧米茄 3 脂肪酸移植"。 结果 得出 43 项声明,并将其分为 5 个部分,包括针对 LEW 的一般性建议以及针对 DFU、VLU、非典型 LEW 和创伤性 LEW 的具体建议。主要的一般性建议是需要根据临床评估和相关检查结果确定伤口病因。对于 DFU 和 VLU,主要建议是在采用 IFSG 之前坚持一线治疗(即标准护理、遵循常规指南 [多层加压疗法]、卸载和评估伤口灌注)。 结论 在过去几年中,关于使用 IFSG 的出版物和临床经验大幅增加。这 43 项共识建议旨在指导医生在治疗急性和慢性 LEWs 时最佳使用 IFSG。
{"title":"Consensus recommendations for optimizing the use of intact fish skin graft in the management of acute and chronic lower extremity wounds.","authors":"Anthony Tickner, Frank Aviles, Robert Kirsner, E. Lullove, Leah Main, Mark Suski, Naz Wahab, J. C. Lantis Ii","doi":"10.25270/wnds/23130","DOIUrl":"https://doi.org/10.25270/wnds/23130","url":null,"abstract":"BACKGROUND Since 2017, the clinical use of IFSG has increased substantially in the United States, with some use in Europe and Asia as well. However, scant consensus data have been published on such use. OBJECTIVE The authors sought to develop consensus recommendations for the clinical use of IFSG in the management of acute and chronic LEWs. METHODS A panel of 8 expert clinicians in the United States used a 2-cycle NFG process to develop consensus statements based on their own clinical practice and the literature. At their initial meeting in October 2021, panel members discussed the management of DFUs, VLUs, atypical LEWs, and traumatic LEWs in their practices. Consensus statements were drafted, voted on, and rated by relative importance. At the second meeting in October 2022, the panel discussed the initial survey results; a second survey was conducted, and panel members revised the recommendations and indicated the relative importance of each in the final report. A systematic literature review of English-language articles published from January 2016 through November 2022 was conducted as well, using the search terms: \"fish skin,\" \"piscine graft,\" \"fish tissue,\" \"intact fish skin graft,\" \"Cod skin,\" \"Omega 3 fatty acid graft.\" RESULTS Forty-three statements were generated and grouped into 5 sections comprising general recommendations for LEWs and recommendations specific to DFUs, VLUs, atypical LEWs, and traumatic LEWs. The primary general recommendation is the need to determine wound etiology based on clinical evaluation and reviewing related test results. For DFUs and VLUs, the main recommendations are to adhere to first-line therapy (ie, standard of care, follow conventional guidelines [multilayer compression therapy], offloading, and assessment of wound perfusion) before introducing IFSG. CONCLUSIONS Publications on and clinical experience in the use of IFSGs have increased substantially in the past several years. The 43 consensus recommendations are meant to guide physicians in the optimal use of IFSG in the management of acute and chronic LEWs.","PeriodicalId":23752,"journal":{"name":"Wounds : a compendium of clinical research and practice","volume":"115 1","pages":"E376-E390"},"PeriodicalIF":1.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139303758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anchoring flap suture technique to repair a wound with exposed bone after hip disarticulation: a case report and brief review of the literature. 锚定皮瓣缝合技术修复髋关节脱臼后骨外露创面:1例报告及文献回顾。
IF 1.7 4区 医学 Q3 DERMATOLOGY Pub Date : 2023-11-01
Zhiyuan Shi, Ming Zhang, Xingtong Wang, Minhui Zhu, Xiangbo Ye

Background: In specific clinical scenarios characterized by poor tissue conditions surrounding a wound, achieving stable flap fixation with standard sutures can be challenging. The anchoring flap suture technique, which is commonly used for soft tissue-to-bone attachment in cases of injury, may be an alternative and effective approach.

Case report: This report describes the successful application of the anchoring flap suture technique to repair a wound with exposed bone in a 39-year-old female patient. She presented with a 7% TBSA wound of the left trunk following hip disarticulation. After 4 operations, a wound with exposed iliac bone remained. Given the compromised condition of the tissues surrounding the exposed bone, the authors opted to anchor a local flap directly to the exposed bone. Steady flap fixation was achieved using the anchoring flap suture method, resulting in complete healing of that wound. Remarkably, no short- or long-term complications associated with the flap were observed. Three months after hospital discharge, the patient regained mobility, walking on 1 leg with the assistance of a 4-legged walker.

Conclusion: The anchoring flap suture technique seems to be a reliable and effective treatment option, particularly in cases in which inadequate soft tissue precludes the use of traditional flap fixation using standard sutures.

背景:在特定的临床情况下,以伤口周围的组织状况不佳为特征,用标准缝线实现稳定的皮瓣固定是具有挑战性的。锚定皮瓣缝合技术通常用于软组织与骨的连接,可能是一种替代和有效的方法。病例报告:本报告描述了一名39岁女性患者成功应用锚定皮瓣缝合技术修复骨外露伤口。她表现为髋关节脱臼后左躯干有7% TBSA的伤口。4次手术后,仍有1例髂骨外露。考虑到暴露骨周围组织受损的情况,作者选择将局部皮瓣直接锚定在暴露骨上。采用锚定皮瓣缝合法实现皮瓣稳定固定,创面完全愈合。值得注意的是,没有观察到与皮瓣相关的短期或长期并发症。出院3个月后,患者恢复活动能力,在4腿助行器的帮助下单腿行走。结论:锚定皮瓣缝合技术似乎是一种可靠和有效的治疗选择,特别是在软组织不足,无法使用传统的标准缝合皮瓣固定的情况下。
{"title":"Anchoring flap suture technique to repair a wound with exposed bone after hip disarticulation: a case report and brief review of the literature.","authors":"Zhiyuan Shi, Ming Zhang, Xingtong Wang, Minhui Zhu, Xiangbo Ye","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>In specific clinical scenarios characterized by poor tissue conditions surrounding a wound, achieving stable flap fixation with standard sutures can be challenging. The anchoring flap suture technique, which is commonly used for soft tissue-to-bone attachment in cases of injury, may be an alternative and effective approach.</p><p><strong>Case report: </strong>This report describes the successful application of the anchoring flap suture technique to repair a wound with exposed bone in a 39-year-old female patient. She presented with a 7% TBSA wound of the left trunk following hip disarticulation. After 4 operations, a wound with exposed iliac bone remained. Given the compromised condition of the tissues surrounding the exposed bone, the authors opted to anchor a local flap directly to the exposed bone. Steady flap fixation was achieved using the anchoring flap suture method, resulting in complete healing of that wound. Remarkably, no short- or long-term complications associated with the flap were observed. Three months after hospital discharge, the patient regained mobility, walking on 1 leg with the assistance of a 4-legged walker.</p><p><strong>Conclusion: </strong>The anchoring flap suture technique seems to be a reliable and effective treatment option, particularly in cases in which inadequate soft tissue precludes the use of traditional flap fixation using standard sutures.</p>","PeriodicalId":23752,"journal":{"name":"Wounds : a compendium of clinical research and practice","volume":"35 11","pages":"E403-E407"},"PeriodicalIF":1.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138483144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment: enhancing complex wound care by leveraging artificial intelligence. 点评:利用人工智能加强复杂伤口护理。
IF 1.7 4区 医学 Q3 DERMATOLOGY Pub Date : 2023-10-01
Amnuay Kleebayoon, Viroj Wiwanitkit
{"title":"Comment: enhancing complex wound care by leveraging artificial intelligence.","authors":"Amnuay Kleebayoon, Viroj Wiwanitkit","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":23752,"journal":{"name":"Wounds : a compendium of clinical research and practice","volume":"35 10","pages":"E329"},"PeriodicalIF":1.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92156857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of risk factors for foot ulceration in individuals with chronic kidney disease. 慢性肾脏疾病患者足部溃疡的危险因素评估
IF 1.7 4区 医学 Q3 DERMATOLOGY Pub Date : 2023-10-01
Vacide Aşık Özdemir, Nesrin Nural

Introduction: CKD, like DM, is an independent risk factor for the development and course of foot ulcers.

Objective: The authors studied the incidence and risk factors of foot ulceration in patients with CKD and with or without DM and in patients receiving or not receiving HD.

Materials and methods: Patients with or without DM and with renal failure were divided into 4 groups of 40 patients each according to whether or not they were receiving HD. Data were collected using a patient information form, physical examination of the foot, and risk assessment forms.

Results: Lower extremity ulceration was highest in group 3 (HD+DM+) (15% [6 of 40]), that is, in patients with CKD and DM receiving HD (P = .421). Patients in group 3 were at highest risk for foot ulcers (72.5%) compared with other groups (P = .001). Risk factors associated with foot ulceration were advanced stage (ie, stage 4 or 5) CKD, HD treatment, age, BMI, history of lower extremity ulceration and/or amputation, foot deformities, skin and nail pathology, neuropathy, and vascular insufficiency.

Conclusions: Patients with CKD receiving HD are at high risk for foot ulcers, and this risk increases with the presence of DM.

简介:CKD与DM一样,是足部溃疡发展和病程的独立危险因素。目的:研究CKD合并或不合并DM患者、接受或未接受HD患者足部溃疡的发生率及危险因素。材料与方法:将合并或不合并DM、合并肾功能衰竭的患者根据是否接受HD分为4组,每组40例。使用患者信息表、足部体格检查和风险评估表收集数据。结果:组3 (HD+DM+)下肢溃疡发生率最高(15%[6 / 40]),即CKD和DM合并HD患者下肢溃疡发生率最高(P = .421)。与其他组相比,第3组患者发生足部溃疡的风险最高(72.5%)(P = 0.001)。与足部溃疡相关的危险因素有:CKD晚期(即4期或5期)、HD治疗、年龄、BMI、下肢溃疡和/或截肢史、足部畸形、皮肤和指甲病理、神经病变和血管功能不全。结论:CKD合并HD的患者发生足部溃疡的风险较高,并且这种风险随着DM的存在而增加。
{"title":"Evaluation of risk factors for foot ulceration in individuals with chronic kidney disease.","authors":"Vacide Aşık Özdemir, Nesrin Nural","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>CKD, like DM, is an independent risk factor for the development and course of foot ulcers.</p><p><strong>Objective: </strong>The authors studied the incidence and risk factors of foot ulceration in patients with CKD and with or without DM and in patients receiving or not receiving HD.</p><p><strong>Materials and methods: </strong>Patients with or without DM and with renal failure were divided into 4 groups of 40 patients each according to whether or not they were receiving HD. Data were collected using a patient information form, physical examination of the foot, and risk assessment forms.</p><p><strong>Results: </strong>Lower extremity ulceration was highest in group 3 (HD+DM+) (15% [6 of 40]), that is, in patients with CKD and DM receiving HD (P = .421). Patients in group 3 were at highest risk for foot ulcers (72.5%) compared with other groups (P = .001). Risk factors associated with foot ulceration were advanced stage (ie, stage 4 or 5) CKD, HD treatment, age, BMI, history of lower extremity ulceration and/or amputation, foot deformities, skin and nail pathology, neuropathy, and vascular insufficiency.</p><p><strong>Conclusions: </strong>Patients with CKD receiving HD are at high risk for foot ulcers, and this risk increases with the presence of DM.</p>","PeriodicalId":23752,"journal":{"name":"Wounds : a compendium of clinical research and practice","volume":"35 10","pages":"E319-E328"},"PeriodicalIF":1.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92156859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of wound surface area measurements obtained using clinically validated artificial intelligence-based technology versus manual methods and the effect of measurement method on debridement code reimbursement cost. 使用经临床验证的人工智能技术与人工方法测量伤口表面积的比较,以及测量方法对清创代码报销费用的影响。
IF 1.7 4区 医学 Q3 DERMATOLOGY Pub Date : 2023-10-01 DOI: 10.25270/wnds/23031
Misael C Alonso, Heba Tallah Mohammed, Robert D Fraser, J. L. Ramírez García Luna, David Mannion
BACKGROUND Evidence shows that ongoing accurate wound assessments using valid and reliable measurement methods is essential to effective wound monitoring and better wound care management. Relying on subjective interpretation in measuring wound dimensions and assuming a rectilinear shape of all wounds renders an inconsistent and inaccurate wound area measurement. OBJECTIVE The authors investigated the discrepancy in wound area measurements using a DWMS versus TPR methods and compared debridement codes submitted for reimbursement by assessment method. METHODS The width and length of 177 wounds in 56 patients were measured at an outpatient clinic in the United States using the TPR method (width × length formula) and a DWMS (traced wound dimensions). The maximal allowable payment for debridement was calculated for both methods using the reported CPT codes based on each 20-cm2 estimated surface area. RESULTS The average wound surface area was significantly higher with the TPR method than with the DWMS (20.20 and 12.81, respectively; P = .025). For patients with dark skin tones, ill-defined wound edges, irregular wound shapes, unhealthy tissues, and the presence of necrotic tissues, the use of the DWMS resulted in significantly lower mean differences in wound area measurements of 14.4 cm2 (P < .008), 8.2 cm2 (P = .040), 6.8 cm2 (P = .045), 13.1 cm2 (P = .036), and 7.6 cm2 (P = .043), respectively, compared with the TPR method. Use of the DWMS for wound surface area measurement resulted in a 10.6% lower reimbursement amount for debridement, with 82 fewer submitted codes, compared with the TPR method. CONCLUSIONS Compared with the DWMS, TPR measurements overestimated wound area more than 36.6%. This overestimation was associated with dark skin tones and wounds with irregular edges, irregular shapes, and necrotic tissue.
背景 有证据表明,使用有效可靠的测量方法持续进行准确的伤口评估,对于有效监测伤口和改善伤口护理管理至关重要。依靠主观解释来测量伤口尺寸以及假设所有伤口的形状都是直线形,会导致伤口面积测量结果不一致且不准确。 目的 作者调查了使用 DWMS 和 TPR 方法测量伤口面积的差异,并比较了按评估方法提交报销的清创代码。 方法 在美国一家门诊诊所使用 TPR 方法(宽度 × 长度公式)和 DWMS(追踪伤口尺寸)测量了 56 名患者 177 处伤口的宽度和长度。根据每 20 平方厘米的估计表面积,使用报告的 CPT 代码计算两种方法的最大清创允许费用。 结果 TPR 法的平均伤口表面积明显高于 DWMS 法(分别为 20.20 和 12.81;P = .025)。对于肤色较深、伤口边缘不清晰、伤口形状不规则、组织不健康和存在坏死组织的患者,与 TPR 方法相比,使用 DWMS 测量伤口面积的平均差异明显较低,分别为 14.4 平方厘米 (P < .008)、8.2 平方厘米 (P = .040)、6.8 平方厘米 (P = .045)、13.1 平方厘米 (P = .036) 和 7.6 平方厘米 (P = .043)。与 TPR 方法相比,使用 DWMS 测量伤口表面积导致清创报销金额降低了 10.6%,提交的代码减少了 82 个。 结论 与 DWMS 相比,TPR 测量法高估的伤口面积超过 36.6%。这种高估与深肤色以及边缘不规则、形状不规则和有坏死组织的伤口有关。
{"title":"Comparison of wound surface area measurements obtained using clinically validated artificial intelligence-based technology versus manual methods and the effect of measurement method on debridement code reimbursement cost.","authors":"Misael C Alonso, Heba Tallah Mohammed, Robert D Fraser, J. L. Ramírez García Luna, David Mannion","doi":"10.25270/wnds/23031","DOIUrl":"https://doi.org/10.25270/wnds/23031","url":null,"abstract":"BACKGROUND Evidence shows that ongoing accurate wound assessments using valid and reliable measurement methods is essential to effective wound monitoring and better wound care management. Relying on subjective interpretation in measuring wound dimensions and assuming a rectilinear shape of all wounds renders an inconsistent and inaccurate wound area measurement. OBJECTIVE The authors investigated the discrepancy in wound area measurements using a DWMS versus TPR methods and compared debridement codes submitted for reimbursement by assessment method. METHODS The width and length of 177 wounds in 56 patients were measured at an outpatient clinic in the United States using the TPR method (width × length formula) and a DWMS (traced wound dimensions). The maximal allowable payment for debridement was calculated for both methods using the reported CPT codes based on each 20-cm2 estimated surface area. RESULTS The average wound surface area was significantly higher with the TPR method than with the DWMS (20.20 and 12.81, respectively; P = .025). For patients with dark skin tones, ill-defined wound edges, irregular wound shapes, unhealthy tissues, and the presence of necrotic tissues, the use of the DWMS resulted in significantly lower mean differences in wound area measurements of 14.4 cm2 (P < .008), 8.2 cm2 (P = .040), 6.8 cm2 (P = .045), 13.1 cm2 (P = .036), and 7.6 cm2 (P = .043), respectively, compared with the TPR method. Use of the DWMS for wound surface area measurement resulted in a 10.6% lower reimbursement amount for debridement, with 82 fewer submitted codes, compared with the TPR method. CONCLUSIONS Compared with the DWMS, TPR measurements overestimated wound area more than 36.6%. This overestimation was associated with dark skin tones and wounds with irregular edges, irregular shapes, and necrotic tissue.","PeriodicalId":23752,"journal":{"name":"Wounds : a compendium of clinical research and practice","volume":"197 1","pages":"E330-E338"},"PeriodicalIF":1.7,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139328995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Wounds : a compendium of clinical research and practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1